Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 440.29B | 467.90B | 389.63B | 320.95B | 277.75B | 366.59B |
Gross Profit | 192.39B | 196.74B | 158.07B | 127.87B | 100.78B | 136.50B |
EBITDA | 62.06B | 58.61B | 59.64B | 45.76B | 7.36B | 46.88B |
Net Income | 39.48B | 33.05B | 45.94B | 37.03B | 1.27B | 13.78B |
Balance Sheet | ||||||
Total Assets | 645.67B | 653.99B | 501.57B | 435.49B | 421.60B | 458.27B |
Cash, Cash Equivalents and Short-Term Investments | 202.35B | 219.81B | 179.51B | 152.46B | 155.69B | 164.41B |
Total Debt | 153.25B | 161.84B | 57.35B | 56.01B | 56.81B | 75.33B |
Total Liabilities | 262.59B | 296.30B | 170.22B | 142.85B | 130.34B | 161.41B |
Stockholders Equity | 383.05B | 357.67B | 331.32B | 292.59B | 290.76B | 294.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 54.72B | 33.88B | 27.75B | -21.39B | 19.50B |
Operating Cash Flow | 0.00 | 65.83B | 44.70B | 39.61B | -6.38B | 38.54B |
Investing Cash Flow | 0.00 | -113.51B | -2.35B | -8.79B | 30.47B | -15.46B |
Financing Cash Flow | 0.00 | 79.79B | -15.36B | -35.97B | -31.49B | -10.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | $82.72B | 19.05 | 23.93% | 2.04% | 1.26% | 6.84% | |
72 Outperform | $4.63B | 17.40 | 11.92% | 1.62% | -12.56% | -24.47% | |
72 Outperform | $71.62B | ― | -460.30% | ― | 30.24% | 27.61% | |
71 Outperform | $8.67B | ― | -4.29% | ― | 21.11% | 87.93% | |
70 Outperform | $39.64B | 37.15 | 16.13% | 0.48% | -0.81% | -9.28% | |
61 Neutral | $41.22B | -1.26 | -14.49% | 3.95% | 2.29% | -73.14% | |
57 Neutral | $42.84B | ― | -114.76% | ― | 5.31% | -15.57% |